Search results
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 4 hours agoA young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy...
Pfizer reports patient death in Duchenne gene therapy study
WSAU Wausau· 2 hours ago(Reuters) - A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer's...
Pfizer Pauses Gene Therapy Trial for Muscle Disease After Death
Bloomberg· 4 hours agoPfizer Inc. paused a study of an experimental gene therapy for muscular dystrophy after a child who...
Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SEC
Reuters· 4 hours agoPharma company Pfizer told a New York federal judge on Monday that it is entitled to recoup about...
Patient dies in Pfizer study of Duchenne gene therapy
BioPharma Dive via Yahoo Finance· 7 hours agoPfizer said the patient, a young boy who was treated earlier last year, had died suddenly. The...
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 3 days agoReaders hoping to buy Pfizer Inc. (NYSE:PFE) for its dividend will need to make their move shortly,...
Market Today: Pfizer Pauses Gene Therapy Trial After Patient Dea
Guru Focus· 1 hour agoThe stock market exhibited mixed results at the close today. The Nasdaq Composite edged down by...
Pfizer First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 13 hours agoPfizer (NYSE:PFE) First Quarter 2024 Results Key Financial Results Revenue: US$14.9b (down 19% from...
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 4 hours agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
Cramer explains how to maintain a 'balanced' portfolio as the economy slows
CNBC· 1 hour agoCNBC's Jim Cramer on Tuesday said Wall Street is currently going through a tricky stage of the...